Time is critical for the thousands of patients that suffer from an ST-elevation myocardial infarction (STEMI) each year. Current American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend that a hospital’s door-to-balloon (D2B) times for STEMI patients be 90 minutes or less, starting from the moment patients enter the emergency department (ED) to the second a percutaneous coronary intervention (PCI) is performed. Hospitals with catherization laboratories are using a range of methods, varying from the use of advanced technologies to the implementation of certain protocols, to meet this target and shave off their D2B times.



There has been much discussion about how use of transradial access may help reduce costs by cutting hospital admissions, length of stay and observation periods, while also reducing bleeding complications and the need for transfusions. Few centers could offer hard numbers showing these savings, however empirical evidence is now surfacing that these statements are true. The numbers show that transradial programs are impacting several hospitals’ bottom lines. 

 

Agfa HealthCare's stated core belief is centered around helping imaging providers succeed, yet a majority of U.S. clients interviewed by KLAS report gaps in reaching desired results when using Agfa as a vendor. The reasons and other details can be found in the new KLAS vendor-specific report Agfa HealthCare Study 2013: Partnering with Agfa in 2013.

Fujifilm Medical Systems U.S.A. Inc. launched the Synapse Vendor Neutral Archive (VNA) into its informatics portfolio. The technology will enable customers to manage all types of data generated within their healthcare institution. Instead of the data being standards or non-standards based, Synapse VNA technology will catalog and maintain the data in a patient centric model allowing a single access point for EMRs and other systems.

TeraRecon highlighted the broad capability of its flagship iNtuition enterprise image management solution to support enterprise-wide vendor-neutral viewing of medical images, at the annual meeting of the Healthcare Information and Management Systems Society, (HIMSS), March 4-6, 2013.


 

Bayer Healthcare is expanding its global distribution network for the Medrad Intego positron emission tomography (PET) Infusion System through a new distribution agreement with Comecer SPA. Through this agreement, Bayer and Comecer are providing customers with an integrated nuclear medicine solution – combining the clinical administration capabilities of Intego with the Comecer's protection technologies for PET/CT centers around the world.

 

Researchers at The Johns Hopkins University and Yale University have discovered that a specialized receptor, normally found in the nose, is also in blood vessels throughout the body, sensing small molecules created by microbes that line mammalian intestines, and responding to these molecules by increasing blood pressure. The finding suggests that gut bacteria are an integral part of the body’s complex system for maintaining a stable blood pressure.


Subscribe Now